Articles in Business

Zacks.com

JPMorgan to Redeem $1.7B Worth of Subordinated Notes - Analyst Blog

JPMorgan Chase & Co. ( JPM ) is planning to redeem callable subordinated notes worth nearly $1.7 billion. The following series of fixed floating rate subordinated notes will be redeemed The... Read >>

Zacks.com

Cisco, Belgacom Extend Alliance to Boost Internet Services - Analyst Blog

Cisco Systems, Inc. ( CSCO ) announced the extension of its partnership with Belgian telecommunications company Belgacom, which is in the process of upgrading its network. Belgacom has purchased... Read >>

Zacks.com

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog

VIVUS, Inc. ( VVUS ) and Auxilium Pharmaceuticals, Inc. ( AUXL ) announced that the FDA has approved their erectile dysfunction (ED) drug, Stendra's (EU trade name Spedra) supplemental new drug... Read >>

Zacks.com

Covidien Sonicision Line Expands, 3 Devices Gain FDA Nod - Analyst Blog

Covidien plc ( COV ) recently announced the expansion of its Sonicision Cordless Ultrasonic Dissection Device portfolio, following the U.S. Food and Drug Administration (FDA) clearance for three... Read >>

Zacks.com

Qualcomm's Vufuria to Enhance Digital Eyewear Range - Analyst Blog

In an attempt to enhance mobile vision technology, Qualcomm Connected Experiences, Inc. the business arm of Qualcomm Inc. ( QCOM ) recently unveiled a solution, Qualcomm Vuforia.  The Vuforia... Read >>

Zacks.com

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Salix Pharmaceuticals, Ltd.'s ( SLXP ) supplemental new drug application (sNDA) for Xifaxan 550 has been accepted for review by the FDA. The company is looking to expand the use of Xifaxan 550 for... Read >>

Zacks.com

Haemonetics (HAE) Poised on Strong Q2, Optimistic Outlook - Analyst Blog

On Sep 19, 2014, we issued an updated research report on Haemonetics Corporation ( HAE ) a global provider of blood management solutions. Haemonetics reported an impressive first quarter of fiscal... Read >>

Zacks.com

Lindsay's Capital Allocation Initiative Shows Potential - Analyst Blog

On Sep 18, 2014, we issued an updated research report on Lindsay Corporation ( LNN ). The designer and manufacturer of self propelled center pivot and lateral move irrigation systems is poised to... Read >>

Zacks.com

athenahealth Up to Buy on High EHR Adoption - Analyst Blog

On Sep 17, Zacks Investment Research upgraded athenahealth, Inc. ( ATHN ) by a notch to a Zacks Rank #2 (Buy).   Why the Upgrade? This leading provider of cloud based services and mobile tools for... Read >>

Zacks.com

Visa's Growth to Be Affected by Litigations, Regulations? - Analyst Blog

On Sep 18, we issued an updated research report on Visa Inc. ( V ). Higher competition, stringent regulations and the possibility of adverse outcomes of the ongoing litigations raise both... Read >>